Last reviewed · How we verify
panfotocoagulation (PASCAL)
PASCAL (Pattern Scan Laser) delivers rapid, short-duration laser pulses to create a grid pattern of thermal burns on the retina, inducing photocoagulation to treat retinal diseases.
PASCAL (Pattern Scan Laser) delivers rapid, short-duration laser pulses to create a grid pattern of thermal burns on the retina, inducing photocoagulation to treat retinal diseases. Used for Proliferative diabetic retinopathy, Retinal vein occlusion with neovascularization, Other retinal conditions requiring panretinal photocoagulation.
At a glance
| Generic name | panfotocoagulation (PASCAL) |
|---|---|
| Sponsor | University of Sao Paulo |
| Drug class | Laser photocoagulation device |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
PASCAL is a laser-based technology that performs panretinal photocoagulation through a scanning pattern delivery system, creating multiple small burns across the retina in a single session. This approach aims to reduce treatment time and improve patient comfort compared to traditional continuous-wave photocoagulation while achieving similar therapeutic outcomes by destroying abnormal retinal tissue and reducing hypoxia-driven neovascularization.
Approved indications
- Proliferative diabetic retinopathy
- Retinal vein occlusion with neovascularization
- Other retinal conditions requiring panretinal photocoagulation
Common side effects
- Transient vision reduction
- Retinal burn/scarring
- Cataract progression
- Vitreous hemorrhage
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |